| Health / Medical Topics |
Apomab
A fully human monoclonal antibody directed against human death receptor 5 (DR5; TRAIL-R2; TNFRSF10B) with potential pro-apoptotic and antineoplastic activities. Mimicking the natural ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand), apomab binds to DR5, which may directly activate the extrinsic apoptosis pathway and indirectly induce the intrinsic apoptosis pathway in tumor cells. DR5 is a cell surface receptor of the TNF-receptor superfamily and is expressed in a broad range of cancers. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance being studied in the treatment of hematologic (blood) cancers. Apolizumab binds to a protein called ID10, which is found on…
The determination of the ratio of the apolipoprotein J compared to creatinine present in a sample. The measurement may be expressed as…
The determination of the amount of apolipoprotein J present in a sample.
The determination of the amount of apolipoprotein H present in a sample.
The determination of the amount of apolipoprotein E4 present in a sample.
Apolipoprotein E4 (317 aa, ~36 kDa) is encoded by the human APOE gene. This protein is involved in triglyceride metabolism.
